HYBRID EVENT: Join us in person in Tokyo, Japan or attend virtually from anywhere.
7th Edition of Cardiology World Conference
October 08-10, 2026 | Virtual Event
Cardiovascular Translational Research
Cardiovascular Translational Research
According to Translational research in Cardiology, it is the method of using advanced procedures to promote their importance in fields of cardiovascular disease, diagnosis and treatment to speed up scientific discovery into patient and future community benefit.It addresses critical medical needs. In applied sciences, it is specifically designed to improve health outcomes. Types of Translational Research:
- T1 research
- T2 research
- T3 research
- T4 research
Committee Members
Yochai Birnbaum
Baylor College of Medicine, United States
Uwe Peter Tigor
Auxilius Pharma, United States, United States
Federico Benetti
Benetti Foundation, Argentina Cardio 2026 Speakers
Sergey Suchkov
Professor in Medicine & Immunology, Director for Center for Biodesign of N.D. Zelinskii Institute for Organic Chemistry of the Russian Academy of Sciences, Russian Federation
Syed Raza
Awali Hospital, Bahrain
Sekib Sokolovic
ASA Hospital Sarajevo, Bosnia and Herzegowina
Thomas J Webster
Brown University, United StatesSubmit your abstract Today
Title : Chronic angina and the health economics of cardiovascular risk reduction in macro- and microvascular coronary disease
Uwe Peter Tigor, Auxilius Pharma, United States, United States
Title : Vericiguat Inhibits the Progress of Cardiac Hypertrophy and Prevents Hypertrophy Induced Heart Failure by Multiple Mechanisms
Guo Wei He, Tianjin University, China
Title : New mechanisms and innovative therapeutics for pulmonary hypertension
Yong Xiao Wang, Albany Medical Center, United States
Title : STEMI versus acute occlusive myocardial infarction: Which term should we use?
Yochai Birnbaum, Baylor College of Medicine, United States
Title :
Federico Benetti, Benetti Foundation, Argentina
Title : Coronary revascularization in patients with diabetes: Prospects for stenting in patients with type 1 diabetes and coronary artery disease
Mekhman N Mamedov, National Research Center for Therapy and Preventive Medicine, Russian Federation